The present invention relates to a solid oral pharmaceutical composition comprising an inert core comprising, preferably consisting of, at least one acidic reacting compound, and a coating comprising vortioxetine hydrobromide and at least one pharmaceutically acceptable polymer and a method for enhancing the solubility and bioavailability of vortioxetine hydrobromide.